Who is sponsoring NCT03495622?

NCT03495622 is sponsored by University Hospitals Cleveland Medical Center.

What drugs are being tested in NCT03495622?

Interventions in NCT03495622: Motivational Interviewing/Text messaging.

What condition does NCT03495622 study?

NCT03495622 studies Smoking Cessation.

Is NCT03495622 still recruiting?

NCT03495622 is currently completed. Last updated 8 August 2019.

Last reviewed 2019-08-08 · How we verify

NCT03495622: MUKTI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of a Combined CHW and Text Messaging-based Tobacco Intervention in India

Completed NA Last updated 8 August 2019

What this trial tests

NA trial testing Motivational Interviewing/Text messaging in Smoking Cessation in 300 participants. Completed in 1 August 2019.

Timeline

1 January 2018

Primary endpoint
1 August 2019

1 August 2019

Quick facts

Lead sponsor	University Hospitals Cleveland Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	300
Start date	1 January 2018
Primary completion	1 August 2019
Estimated completion	1 August 2019
Sites	2 locations across India

Drugs / interventions tested

Motivational Interviewing/Text messaging

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →

Sponsor

University Hospitals Cleveland Medical Center

Who can join

Adults 18 to 70, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a multi-center 1-year community-based cluster randomized controlled trial to assess the role of a combined community health worker and mobile health intervention in controlling one of the most common cardiovascular risk factors, tobacco use. Participants will include 560 adults, 18-70 years of age, from the urban communities of Dalkhola, West Bengal, and Jabalpur, Madhya Pradesh, India. The hypothesis of the study is that this combined approach can result in increased quit rate among tobacco users.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Mobile phone text messaging and app-based interventions for smoking cessation.
Whittaker R, McRobbie H, Bullen C, Rodgers A, et al · · 2019 · cited 278× · PMID 31638271 · DOI 10.1002/14651858.cd006611.pub5
A combined community health worker and text messagingbased intervention for smoking cessation in India: Project MUKTI - A mixed methods study.
Hejjaji V, Khetan A, Hughes JW, Gupta P, et al · · 2021 · cited 4× · PMID 33791445 · DOI 10.18332/tpc/132469
Rationale and design of a study to test the effectiveness of a combined community health worker and text messaging-based intervention for smoking cessation in India (Project MUKTI).
Khetan A, Hejjaji V, Hughes J, Gupta P, et al · · 2019 · cited 1× · PMID 31380407 · DOI 10.21037/mhealth.2019.05.04

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Other University Hospitals Cleveland Medical Center trials

Trials by the same sponsor.

NCT06997198 — Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities · Phase 4 · not yet recruiting
NCT07379814 — Rectus Abdominis Detrusor Myoplasty for Urinary Retention · not yet recruiting
NCT07499648 — Baby Steps to Care · NA · not yet recruiting
NCT07497737 — OMT for Adhesive Capsulitis · Phase 4 · not yet recruiting
NCT06523166 — Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03495622 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospitals Cleveland Medical Center
Last refreshed: 8 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03495622.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing